enGene Holdings Inc. Common Stock (ENGN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $10.03
• Market Cap: $655.11M
• EPS: $-2.29
• 52-Week High: $12.25
• 52-Week Low: $2.65

Market Sentiment

enGene Holdings Inc. Common Stock currently has a Neutral sentiment score of 0.13.

About enGene Holdings Inc. Common Stock

enGene Holdings Inc. is a clinical-stage biotechnology firm headquartered in Saint-Laurent, Canada, focused on pioneering genetic medicines for the targeted treatment of diseases affecting mucosal tissues and other organs. The company employs cutting-edge delivery technologies to improve the efficacy and safety of its proprietary therapeutic platform, addressing critical unmet medical needs in the field of genetic therapy. With its promising pipeline advancing through clinical trials, enGene ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for enGene Holdings Inc. Common Stock and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ENGN pay dividends?

enGene Holdings Inc. Common Stock (ENGN) does not currently pay a regular dividend.

What is ENGN's market cap?

enGene Holdings Inc. Common Stock (ENGN) has a market capitalization of $655.11M with a current stock price of $10.03.